Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
318
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
+5.22M
-
Total reported value, excl. options
-
$11.5B
-
Value change
-
+$274M
-
Put/Call ratio
-
0.48
-
Number of buys
-
184
-
Number of sells
-
-149
-
Price
-
$81.86
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q4 2024
406 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q4 2024.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 318 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
.
Largest 10 shareholders include FMR LLC (13.1M shares), VANGUARD GROUP INC (12M shares), BlackRock, Inc. (11.1M shares), JANUS HENDERSON GROUP PLC (10.6M shares), RA CAPITAL MANAGEMENT, L.P. (8.69M shares), Capital Research Global Investors (6.21M shares), STATE STREET CORP (4.54M shares), WELLINGTON MANAGEMENT GROUP LLP (4.44M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.97M shares), and GOLDMAN SACHS GROUP INC (3.13M shares).
This table shows the top 318 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.